M&A 09:44 ET · Sep 3, 2026 ● Checked against the source APGE APOGEE THERAPEUTICS Buyout Closes as Shares Head for Delisting An 8-K filing shows Apogee Therapeutics has completed a change-of-control transaction, replaced its board and recapitalized to just 1,000 shares. Andre·2 min read ID: APGE-2026-09-03-0944 TickersAPGE M&A DeskM&A PublishedSep 3, 2026 · 09:44 ET AccessPro story MORE FROM THE DESK Sep 11 · 11:23 ETATAIBECKLEY Delisted as 8-K Points to Completed Eli Lilly TakeoverSep 11 · 06:12 ETARC GROUP ACQUISITION I to Merge With Malaysian Lender at $1.09B ValueSep 10 · 12:02 ETFINGERMOTION Signs Binding MOU for 9.9 MW Powered Land Site in AlbertaSep 10 · 08:46 ETIRISH CONTINENTAL GROUP Shareholders Approve Bluefin BidCo Takeover
